A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

BackgroundNeuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening adverse drug reaction. This study aims to identify the most prevalent drugs associated with the risk of NMS according to the United States Food and Drug Administration (FDA) Adverse Event Reporting System (FAER...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Zhang, Wei Deng, Minjian Wang, Siying Luo, Song Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
neuroleptic malignant syndrome
FAERS
disproportionality analysis
pharmacovigilance
adverse event reports
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1438661/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1438661/full

Similar Items